Valuation: Amedica Corporation

Market Cap 1.25Cr 1.09Cr 1.03Cr 94.13L 1.76Cr 119.45Cr 1.77Cr 12Cr 4.79Cr 61Cr 4.68Cr 4.58Cr 196.12Cr P/E 2026 *
-1.02x
P/E 2027 * -1.45x
Enterprise Value 1.25Cr 1.09Cr 1.03Cr 94.13L 1.76Cr 119.45Cr 1.77Cr 12Cr 4.79Cr 61Cr 4.68Cr 4.58Cr 196.12Cr EV / Sales 2026 *
4.22x
EV / Sales 2027 * 2.35x
Free-Float
77.28%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%-0.12%-25.44%-4.38% 10TCr
+0.35%-1.90%-23.58%-3.12% 1.12TCr
+0.24%-5.05%+90.92%+103.67% 913.11Cr
-1.29%+3.90%-49.08%-66.54% 414.04Cr
-0.91%+6.85%-24.92%+29.07% 248.89Cr
-3.28%+5.47% - - 193.83Cr
+2.11%-8.60%-9.23%-62.08% 198.93Cr
-1.43%+1.02%-22.05%-27.50% 152.94Cr
Average -0.26%-0.73%-9.06%-4.41% 1.7TCr
Weighted average by Cap. +1.55%-3.20%-17.79%+0.67%

Financials

2026 *2027 *
Net sales 29.55L 25.93L 24.49L 22.32L 41.78L 28Cr 42.08L 2.93Cr 1.14Cr 14Cr 1.11Cr 1.09Cr 47Cr 53.01L 46.51L 43.93L 40.03L 74.94L 51Cr 75.48L 5.26Cr 2.04Cr 26Cr 1.99Cr 1.95Cr 83Cr
Net income -1.24Cr -1.09Cr -1.03Cr -93.56L -1.75Cr -118.73Cr -1.76Cr -12Cr -4.76Cr -61Cr -4.65Cr -4.55Cr -194.95Cr -1.13Cr -99.16L -93.66L -85.35L -1.6Cr -108.31Cr -1.61Cr -11Cr -4.34Cr -55Cr -4.24Cr -4.15Cr -177.84Cr
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-